Systemic mastocytosis in a patient with polycythemia vera treated with radioactive phosphorus.
نویسندگان
چکیده
Systemic mastocytosis occurred as a fatal event in a patient with long-standing polycythemia vera. The patient had been treated over the course of 21 yr with radioactive phosphorus. Possible relationships between mastocytosis and polycythemia vera, and also between mastocytosis and treatment with ionizing radiation, are discussed. Histopathologic and electron microscopic findings are illustrated. Difficulties in establishing the diagnosis of mast cell disease in this setting are also described.
منابع مشابه
Evolution of Marginal Zone Lymphoma Towards Myeloproliferative Disorder: A Case Report
Introduction Lymphoma is a hematologic malignancy characterized by nodal or extranodal malignant infiltration by monoclonal lymphoid cells (B lineage cells in 70% of the cases). Its etiology is not precisely known. Prolonged life expectancy has resulted in increase of the disease incidence. Marginal zone lymphoma is a low-grade small B-cell lymphoma incorporated in the World Health Organization...
متن کاملUracil mustard in the treatment of thrombocythemia.
T HROMBOCYTHEN’IIA with platelet counts of over 1,000,000 per cu. mm. may occur in a number of myeloproliferative disorders and may be associated with both thrombosis and hemorrhage. Either busulphan or radioactive phosphorus is generally used to reduce high platelet counts when they occur in these disorders. However, neither of these means of treatment is entirely satisfactory. A prolonged cou...
متن کاملComplex Arterial and Venous Thrombosis in Polycythemia Vera: what Does Leukocytosis Predict?
Thromboembolic events represent the main cause of morbidity and mortality in patients with polycythemia vera. Leukocytosis has been identified as an important risk factor for development of vascular thrombosis. A 47-year-old woman with polycythemia vera presented with pain and swelling in her right calf. She was scheduled to receive anagrelide which was effective on polycythemia and thrombocyto...
متن کاملDecrease in JAK2 V617F allele burden is not a prerequisite to clinical response in patients with polycythemia vera.
BACKGROUND Although reduction in the JAK2(V617F) allele burden (%V617F) has been suggested as a criterion for defining disease response to cytoreductive therapy in polycythemia vera, its value as a response monitor is unclear. The purpose of this study is to determine whether a reduction in %V617F in polycythemia vera is a prerequisite to achieving hematologic remission in response to cytoreduc...
متن کاملHistological changes produced by a single large injection of radioactive phosphorus (P32) in albino rats and in C3H mice.
Numerous reports have appeared, describing the therapeutic use of radioactive phosphorus (P32) in polycythemia vera (5-7, 10, 11, 15, 19, 22, 23), leukemia (4, 5, 7, 9, 13-16, 19, 22-25), and other conditions (10, 12, 22). However, there have been few systematic investigations of the effects of radiophosphorus on the histological appearance of organs and tissues (1, 8, 21). An attempt was there...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Blood
دوره 49 4 شماره
صفحات -
تاریخ انتشار 1977